Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
Crossref DOI link: https://doi.org/10.1186/s12885-015-1675-1
Published Online: 2015-10-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eto, Masatoshi
,
Kawano, Yoshiaki
Hirao, Yoshihiko
Mita, Koji
Arai, Yoichi
Tsukamoto, Taiji
Hashine, Katsuyoshi
Matsubara, Akio
Fujioka, Tomoaki
Kimura, Go
Shinohara, Nobuo
Tatsugami, Katsunori
Hinotsu, Shiro
Naito, Seiji
License valid from 2015-10-09